These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 2166963)
41. Inotropic effects of diadenosine monophosphate (AP1A) in isolated human cardiac preparations. Zimmermann N; Nacke PR; Neumann J; Winter J; Gams E J Cardiovasc Pharmacol; 2000 Jun; 35(6):881-6. PubMed ID: 10836721 [TBL] [Abstract][Full Text] [Related]
42. Chronic beta 1-adrenoceptor antagonist treatment sensitizes beta 2-adrenoceptors, but desensitizes M2-muscarinic receptors in the human right atrium. Motomura S; Deighton NM; Zerkowski HR; Doetsch N; Michel MC; Brodde OE Br J Pharmacol; 1990 Oct; 101(2):363-9. PubMed ID: 1979509 [TBL] [Abstract][Full Text] [Related]
43. Myocardial anti-ischemic characteristics of a novel class of beta-adrenoceptor blockers. Mousa SA; Patil G; Mayo MC; Tong TM Int J Clin Pharmacol Ther Toxicol; 1992 Mar; 30(3):103-6. PubMed ID: 1354656 [TBL] [Abstract][Full Text] [Related]
44. Antimuscarinic action of doxorubicin does not involve free-radical formation in isolated guinea pig hearts. Sasaki T; Ueno S; Hara Y; Uchide T; Temma K Can J Physiol Pharmacol; 2010 Jan; 88(1):77-81. PubMed ID: 20130742 [TBL] [Abstract][Full Text] [Related]
45. Affinities of full agonists for cardiac beta-adrenoceptors calculated by use of in vitro desensitization. Herepath ML; Broadley KJ Naunyn Schmiedebergs Arch Pharmacol; 1990 Jun; 341(6):525-33. PubMed ID: 1975429 [TBL] [Abstract][Full Text] [Related]
47. Modulation of the in vitro cardiotoxicity of doxorubicin by flavonoids. Hüsken BC; de Jong J; Beekman B; Onderwater RC; van der Vijgh WJ; Bast A Cancer Chemother Pharmacol; 1995; 37(1-2):55-62. PubMed ID: 7497597 [TBL] [Abstract][Full Text] [Related]
48. Nature of the antiadrenergic properties of an indolizine. Polster P; Charlier R Arzneimittelforschung; 1978; 28(12):2232-5. PubMed ID: 582936 [TBL] [Abstract][Full Text] [Related]
49. Time-related increases in cardiac concentrations of doxorubicinol could interact with doxorubicin to depress myocardial contractile function. Mushlin PS; Cusack BJ; Boucek RJ; Andrejuk T; Li X; Olson RD Br J Pharmacol; 1993 Nov; 110(3):975-82. PubMed ID: 8298821 [TBL] [Abstract][Full Text] [Related]
50. Inotropic and chronotropic effects of propranolol in isolated atrium of rats with fructose-induced insulin-resistance. Rodríguez G; Mago N Invest Clin; 2017 Mar; 58(1):22-33. PubMed ID: 29939000 [TBL] [Abstract][Full Text] [Related]
51. Chronic doxorubicin induced cardiomyopathy in rabbits: mechanical, intracellular action potential, and beta adrenergic characteristics of the failing myocardium. Shenasa H; Calderone A; Vermeulen M; Paradis P; Stephens H; Cardinal R; de Champlain J; Rouleau JL Cardiovasc Res; 1990 Jul; 24(7):591-604. PubMed ID: 2170016 [TBL] [Abstract][Full Text] [Related]
52. Reactive oxygen species potentiate the negative inotropic effect of cardiac M2-muscarinic receptor stimulation. Peters SL; Sand C; Batinik HD; Pfaffendorf M; van Zwieten PA Naunyn Schmiedebergs Arch Pharmacol; 2001 Aug; 364(2):166-71. PubMed ID: 11534856 [TBL] [Abstract][Full Text] [Related]
53. Simultaneous assessment of membrane-stabilizing and beta-adrenoceptor blocking activity of drugs with the rat isolated left atria. Doggrell SA J Pharmacol Methods; 1988 Apr; 19(2):93-107. PubMed ID: 2896276 [TBL] [Abstract][Full Text] [Related]
54. Secretin-induced changes in rate, contractility and adenylate cyclase activity in rat heart atria. Robberecht P; De Neef P; Waelbroeck M; Camus JC; Fontaine J; Christophe J Pflugers Arch; 1984 May; 401(1):1-5. PubMed ID: 6540864 [TBL] [Abstract][Full Text] [Related]
55. Contribution of 4-hydroxy-2,3-trans-nonenal to the reduction of beta-adrenoceptor function in the heart by oxidative stress. Haenen GR; Plug HJ; Vermeulen NP; Timmerman H; Bast A Life Sci; 1989; 45(1):71-6. PubMed ID: 2545991 [TBL] [Abstract][Full Text] [Related]
56. Ameliorative effects of ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane] on the cardiotoxicity induced by doxorubicin or by isoproterenol in the mouse. Flandina C; Sanguedolce R; Rausa L; D'Alessandro N Res Commun Chem Pathol Pharmacol; 1990 Dec; 70(3):259-72. PubMed ID: 2128759 [TBL] [Abstract][Full Text] [Related]
57. Cardiotoxic effects and the influence on the beta-adrenoceptor function of doxorubicin (Adriamycin) in the rat. Rasmussen IM; Schou HS; Hermansen K Pharmacol Toxicol; 1989 Jul; 65(1):69-72. PubMed ID: 2550922 [TBL] [Abstract][Full Text] [Related]
58. Direct effects of hydralazine on cardiac contractile function, haemodynamics, and myocardial energetics in isolated myocardium. Rendig SV; Segel LD; Amsterdam EA Cardiovasc Res; 1988 May; 22(5):322-8. PubMed ID: 3191517 [TBL] [Abstract][Full Text] [Related]
59. Endogenous muscarinic activity attenuates adrenergic inotropic effects in field stimulated atrial myocardium from children with congenital heart defects. Borthne K; Langslet A; Lindberg H; Osnes JB; Skomedal T Acta Physiol Scand; 1999 Jan; 165(1):9-13. PubMed ID: 10072091 [TBL] [Abstract][Full Text] [Related]
60. Positive chronotropic and inotropic effects of higenamine and its enhancing action on the aconitine-induced tachyarrhythmia in isolated murine atria. Kimura I; Makino M; Takamura Y; Islam MA; Kimura M Jpn J Pharmacol; 1994 Sep; 66(1):75-80. PubMed ID: 7861670 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]